“…With the aim to synthesize new antitumor agents based on organotin(IV), silver(I) or antimony(III) compounds we studied the interaction of R 3 SnCl and R 2 SnCl 2 (R = phenyl-, n-butyl-, methyl-) [17][18][19][20][21], AgX (X = NO 3 , Cl, Br, I) [22][23][24] or SbCl 3 [25,26] with the thioamides 5-chloro-2-mercapto-benzothiazole (CMBZT), 2-mercaptobenzothiazole (MBZT), 2-mercapto-thiazoline (MTZD), 2-mercapto-benzoxazole (MBZO), 2-mercapto-benzimidazole (MBZIM), 5-ethoxy-2-mercapto-benzimidazole (EMBZ-IM), 2-mercapto-pyrimidine (PMTH), 2-mercapto-3,4,5,6-tetrahydro-pyrimidine (STPMH 2 ), 2-mercapto-nicotinic acid (H 2 MNA). In case of silver(I) complexes tri(p-toly)-phosphine (TPTP) was, also, used as ligand [27].…”